• InVivo is dedicated exclusively to developing treatments for spinal cord injury (SCI). We recognize that progress in this field will require multidisciplinary research, development, and extensive collaboration. Our world-class team has built upon years of pioneering research conducted at institutions such as MIT, UCLA, and Boston Children’s Hospital, and we are committed to continuing that collaborative spirit. We are actively searching for thought partners who will advance the field of SCI research.
  • If you would like to speak to InVivo about a potential partnership, please contact Christopher McNulty, Senior Vice President, Business Development & Investor Relations (cmcnulty@invivotherapeutics.com).